Institute for Cancer Research, Yonsei Cancer Center, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Oncol Rep. 2011 Feb;25(2):537-44. doi: 10.3892/or.2010.1079. Epub 2010 Dec 7.
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to activate mitogen-activated protein kinases (MAPKs) depending on caspase and mammalian sterile 20-like kinase 1 activations. However, the upstream molecule of MAPKs has not yet been identified. The mitogen-activated protein kinase kinase 1 (MEKK1) and the apoptosis signal-regulating kinase 1 (ASK1) are considered to be possible candidates for the action of MAPKKKs induced by TRAIL and the possibility of reactive oxygen species involvement has also been investigated. We found that MEKK1/MEKK4 as opposed to ASK1, are responsible for TRAIL-induced c-Jun NH2-terminal kinase (JNK) or p38 activation, and that their catalytic activity is repressed by the caspase-8 inhibitor, suggesting that the caspase-8 activation induced by TRAIL is indispensible for MEKK activation. The 14-3-3 θ was also shown to interact with and to dissociate from MEKK1 by TRAIL treatment, thus implicating the 14-3-3 protein as a negative regulator of MEKK1 activation. Taken together, we show herein that the upstream molecule of the TRAIL-induced MAPK activation is MEKK, as opposed to ASK1, via the mediation of its signal through JNK/p38 in a caspase-8-dependent manner.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)已被证明可根据半胱天冬酶和哺乳动物不育 20 样激酶 1 的激活来激活丝裂原活化蛋白激酶(MAPKs)。然而,MAPKs 的上游分子尚未确定。丝裂原活化蛋白激酶激酶 1(MEKK1)和凋亡信号调节激酶 1(ASK1)被认为是 TRAIL 诱导的 MAPKKKs 作用的可能候选物,并且还研究了活性氧物质参与的可能性。我们发现,MEKK1/MEKK4 与 ASK1 相反,负责 TRAIL 诱导的 c-Jun NH2 末端激酶(JNK)或 p38 的激活,并且它们的催化活性被半胱天冬酶-8 抑制剂抑制,表明 TRAIL 诱导的半胱天冬酶-8 激活对于 MEKK 激活是必不可少的。还表明 TRAIL 处理通过 14-3-3θ与 MEKK1 相互作用并解离,从而暗示 14-3-3 蛋白是 MEKK1 激活的负调节剂。综上所述,我们在此表明,通过半胱天冬酶-8 依赖性方式通过 JNK/p38 介导其信号,TRAIL 诱导的 MAPK 激活的上游分子是 MEKK,而不是 ASK1。